Clinical Trial Update: Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the efficacy of secukinumab in moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Neurodermatitis Atopic

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Dermatitis, Atopic, Eczema, Atopic | Phase 2 | Status: COMPLETED